Increased coverage of voluntary medical male circumcision (VMMC) is needed in countries with high HIV prevalence. We applied an HIV-prevention cascade to identify gaps in male circumcision coverage in Zambia.
HIV/Family planning integration
Resource
April 12, 2019
Resource
April 12, 2019
Unintended pregnancy and HIV infection present dual risks for young women in sub-Saharan Africa. New multipurpose prevention technologies (MPTs) are in development to simultaneously prevent unintended pregnancy and HIV, but there is a need for end-user research to ensure these products suit women's needs. The Tablet, Rings and Injectables as Options (TRIO) for women study took place in Kisumu, Kenya, and Soshanguve, South Africa, with the goal of eliciting young women's feedback on three potential MPTs.
Event
February 12, 2019
Join the Population Council, International Rectal Microbicide Advocates (IRMA)
News
February 5, 2019
Researchers borrow from behavioural economics to understand what women in sub-Saharan Africa really want from a pre-exposure prophylaxis (PrEP) product.
Resource
January 29, 2019
BACKGROUND: In preventing the transfer of HIV to their children, the Ministry of Health in Mozambique recommends all couples
Resource
January 29, 2019
Across sub-Saharan Africa, prevention of mother-to-child transmission services are encountering increasing numbers of women already established on antiretroviral therapy (ART) when entering antenatal care.
Resource
September 11, 2018
The International Partnership for Microbicides (IPM) 2017 annual report takes a look at promising woman-centered technologies that could expand women's prevention options and help empower them to protect their sexual and reproductive health on their own terms.
Resource
July 31, 2018
End-user input is critical to inform development of multipurpose prevention technology (MPT) products that prevent HIV and pregnancy.
Resource
July 23, 2018
A number of antiretroviral HIV prevention products are efficacious in preventing HIV infection.
News
May 29, 2018
Women with HIV who might become pregnant advised to avoid dolutegravir unless using effective contraception
